The proposed project is aimed at evaluation of coronary venous retroperfusion methods for treatment of myocardial ischemia. Prior studies have indicated that synchronized retroperfusion (SRP), during coronary artery occlusions can significantly increase myocardial perfusion and function in the profoundly ischemic zone, along with significantly enhancing viability of the jeopardized myocardium. Recently developed professionally manufactured SRP catheters and an integrated pump system are being evaluated for safety and effectiveness, and clinical trials are anticipated as soon as FDA permission is obtained. Preliminary checks in patients indicate that SRP catheters can be appropriately placed without difficulty and within minutes. Substantial interest in mechanisms and applications of SRP was evident at the first International Symposium on Myocardial Protection via the Coronary Sinus, held in Vienna in February 1984. Most recent laboratory emphasis has been on developing new methods and pilot experiments to elucidate retroperfusion mechanisms, and evaluate SRP techniques. Based on this work, a series of research projects are being proposed which are considered important: 1) assessment of factors affecting effective retrograde coronary venous delivery into ischemic myocardium; 2) extension of the state of the art to clinically pertinent timing of SRP followwing coronary occlusion, longer duration SRP treatment, and determination of post-SRP effects; 3) optimization of moderately hypothermic SRP; 4) retrograde infusion of cardioprotective drugs; 5) further study of retroperfusion protection against reperfusion """"""""no reflow"""""""" derangements of function, metabolism, rhythm, edema/hemorrhages, and myocardial damage; 6) supplemental data on retrograde coronary venous route lysis of a coronary artery thrombus; 7) examination of alternate coronary venous interventions such as the recently proposed pressure controlled intermittent coronary sinus occlusion; 8) SRP during multiple/repetitive brief coronary artery occlusions, to examine retroperfusion treatment for complex PTCA procedures and other clinical states; 9) study of advantages and limitations of intraoperative cardioplegia via coronary sinus retroperfusion; 10) demonstration of integrated SRP system safety and clinical applicability. The significance of the proposed research is that future clinical SRP applications will be based on comprehensive criteria derived from experimental evaluation of methods over an appropriate range of physiologic conditions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL014644-13
Application #
3334827
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1977-12-01
Project End
1990-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
13
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Tadokoro, H; Miyazaki, A; Satomura, K et al. (1996) Infarct size reduction with coronary venous retroinfusion of diltiazem in the acute occlusion/reperfusion porcine heart model. J Cardiovasc Pharmacol 28:134-41
Kobayashi, S; Tadokoro, H; Ryden, L et al. (1993) Local beta-adrenergic blockade does not reduce infarct size after coronary occlusion and reperfusion: a study of coronary venous retroinfusion of metoprolol. Cardiovasc Drugs Ther 7:159-67
Wakida, Y; Nordlander, R; Kobayashi, S et al. (1993) Short-term synchronized retroperfusion before reperfusion reduces infarct size after prolonged ischemia in dogs. Circulation 88:2370-80
Wakida, Y; Haendchen, R V; Kobayashi, S et al. (1991) Percutaneous cooling of ischemic myocardium by hypothermic retroperfusion of autologous arterial blood: effects on regional myocardial temperature distribution and infarct size. J Am Coll Cardiol 18:293-300
Kobayashi, S; Tadokoro, H; Wakida, Y et al. (1991) Coronary venous retroinfusion of deferoxamine reduces infarct size in pigs. J Am Coll Cardiol 18:621-7
Hatori, N; Roberts, R L; Tadokoro, H et al. (1991) Differences in infarct size with lidocaine as compared with bretylium tosylate in acute myocardial ischemia and reperfusion in pigs. J Cardiovasc Pharmacol 18:581-8
Hajduczki, I; Jaffe, M; Areeda, J et al. (1991) Preservation of regional myocardial ultrasonic backscatter and systolic function during brief periods of ischemia by synchronized coronary venous retroperfusion. Am Heart J 122:1300-7
Costantini, C; Sampaolesi, A; Serra, C M et al. (1991) Coronary venous retroperfusion support during high risk angioplasty in patients with unstable angina: preliminary experience. J Am Coll Cardiol 18:283-92
Corday, E; Haendchen, R V (1991) Seminar on coronary venous delivery systems for support and salvage of jeopardized ischemic myocardium--I. Introduction. J Am Coll Cardiol 18:253-6
Kar, S; Drury, J K; Hajduczki, I et al. (1991) Synchronized coronary venous retroperfusion for support and salvage of ischemic myocardium during elective and failed angioplasty. J Am Coll Cardiol 18:271-82

Showing the most recent 10 out of 28 publications